Chapter 1. Point of Care for Sepsis Diagnostics Market – Scope & Methodology
1.1 Market Segmentation
1.2 Scope, Assumptions & Limitations
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Point of Care for Sepsis Diagnostics Market – Executive Summary
2.1 Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.2.1 Demand Side
2.2.2 Supply Side
2.3 Attractive Investment Propositions
2.4 COVID-19 Impact Analysis
Chapter 3. Point of Care for Sepsis Diagnostics Market – Competition Scenario
3.1 Market Share Analysis & Company Benchmarking
3.2 Competitive Strategy & Development Scenario
3.3 Competitive Pricing Analysis
3.4 Supplier-Distributor Analysis
Chapter 4. Point of Care for Sepsis Diagnostics Market Entry Scenario
4.1 Regulatory Scenario
4.2 Case Studies – Key Start-ups
4.3 Customer Analysis
4.4 PESTLE Analysis
4.5 Porters Five Force Model
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Powers of Customers
4.5.3 Threat of New Entrants
4.5.4 Rivalry among Existing Players
4.5.5 Threat of Substitutes
Chapter 5. Point of Care for Sepsis Diagnostics Market – Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Point of Care for Sepsis Diagnostics Market – By Diagnostic Method
6.1 Introduction/Key Findings
6.2 Biomarker Test
6.3 Molecular Diagnostics
6.4 Immunoassays
6.5 Others
6.6 Y-O-Y Growth trend Analysis By Diagnostic Method
6.7 Absolute $ Opportunity Analysis By Diagnostic Method, 2024-2030
Chapter 7. Point of Care for Sepsis Diagnostics Market – By End-User
7.1 Introduction/Key Findings
7.2 Hospitals & Clinics
7.3 Homecare
7.4 Research Laboratories
7.5 Others
7.6 Y-O-Y Growth trend Analysis By End-User
7.7 Absolute $ Opportunity Analysis By End-User, 2024-2030
Chapter 8. Point of Care for Sepsis Diagnostics Market – By Pathogen
8.1 Introduction/Key Findings
8.2 Bacteria
8.3 Fungal
8.4 Viral
8.5 Y-O-Y Growth trend Analysis By Pathogen
8.6 Absolute $ Opportunity Analysis By Pathogen, 2024-2030
Chapter 9. Point of Care for Sepsis Diagnostics Market – By Age
9.1 Introduction/Key Findings
9.2 Pediatric
9.3 Adult
9.4 Geriatric
9.5 Y-O-Y Growth trend Analysis End-User
9.6 Absolute $ Opportunity Analysis End-User, 2024-2030
Chapter 10. Point of Care for Sepsis Diagnostics Market, By Geography – Market Size, Forecast, Trends & Insights
10.1 North America
10.1.1 By Country
10.1.1.1 U.S.A.
10.1.1.2 Canada
10.1.1.3 Mexico
10.1.2 By Diagnostic Method
10.1.2.1 By Age
10.1.3 By By Pathogen
10.2 By End-User
10.2.1 Countries & Segments - Market Attractiveness Analysis
10.3 Europe
10.3.1 By Country
10.3.1.1 U.K
10.3.1.2 Germany
10.3.1.3 France
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Europe
10.3.2 By Diagnostic Method
10.3.3 By End-User
10.3.4 By By Pathogen
10.3.5 By Age
10.3.6 Countries & Segments - Market Attractiveness Analysis
10.4 Asia Pacific
10.4.1 By Country
10.4.1.1 China
10.4.1.2 Japan
10.4.1.3 South Korea
10.4.1.4 India
10.4.1.5 Australia & New Zealand
10.4.1.6 Rest of Asia-Pacific
10.4.2 By Diagnostic Method
10.4.3 By End-User
10.4.4 By By Pathogen
10.4.5 By Age
10.4.6 Countries & Segments - Market Attractiveness Analysis
10.5 South America
10.5.1 By Country
10.5.1.1 Brazil
10.5.1.2 Argentina
10.5.1.3 Colombia
10.5.1.4 Chile
10.5.1.5 Rest of South America
10.5.2 By Diagnostic Method
10.5.3 By End-User
10.5.4 By By Pathogen
10.5.5 By Age
10.5.6 Countries & Segments - Market Attractiveness Analysis
10.6 Middle East & Africa
10.6.1 By Country
10.6.1.1 United Arab Emirates (UAE)
10.6.1.2 Saudi Arabia
10.6.1.3 Qatar
10.6.1.4 Israel
10.6.1.5 South Africa
10.6.1.6 Nigeria
10.6.1.7 Kenya
10.6.1.8 Egypt
10.6.1.9 Rest of MEA
10.6.2 By Diagnostic Method
10.6.3 By End-User
10.6.4 By By Pathogen
10.6.5 By Age
10.6.6 Countries & Segments - Market Attractiveness Analysis
Chapter 11. Point of Care for Sepsis Diagnostics Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
11.1 Siemens
11.2 Abbott
11.3 AdvanDx
11.4 Miacom Diagnostics
11.5 Biofire Diagnostics
11.6 Alteco Medical
11.7 Becton Dickinson
11.8 Wolters Kluwer
11.9 Immunexpress
11.10 Inflammatix
11.11 Mbio
11.12 Abionic
2850
5250
4500
1800
Frequently Asked Questions
The Point of Care For Sepsis Diagnostics Market was valued at USD 470 million and is projected to reach a market size of USD 1001.64 million by the end of 2030. Over the forecast period of 2023-2030, the market is projected to grow at a CAGR of 9.92%.
Increasing cases of sepsis and the Rising geriatric population are the market drivers of the Point of Care For Sepsis Diagnostics market.
Biomarker Tests, Molecular Diagnostics, Immunoassays, and Others, are the segments under the Point of Care For Sepsis Diagnostics Market by diagnostic method.
North America is the most dominant region for the Point of Care For Sepsis Diagnostics Market.
Asia-Pacific is the fastest growing region in the Point of Care For Sepsis Diagnostics Market.